Harborview Medical Center is a public hospital located in the First Hill neighborhood of Seattle, Washington, United States. It is managed by UW Medicine.

There are 413 beds in Harborview Medical Center.

During the past decade, Harborview Medical Center conducted 163 clinical trials. In the 10-year time frame, 163 clinical trials started and 163 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 65 clinical trials were completed. i.e. 114% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Harborview Medical Center" #1 sponsor was "University of Washington" with 90 trials, followed by "SWOG Cancer Research Network" with 83 trials sponsored, "National Cancer Institute (NCI)" with 42 trials sponsored, "Gilead Sciences" with 10 trials sponsored and "Major Extremity Trauma Research Consortium" with 10 trials sponsored. Other sponsors include 199 different institutions and companies that sponsored additional 125 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Harborview Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 97 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 19 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 14 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator and "University of Washington" with 11 trials as a collaborator. Other collaborators include 312 different institutions and companies that were collaborators in the rest 181 trials.

According to Clinical.Site data, the most researched conditions in "Harborview Medical Center" are "Lung Cancer" (17 trials), "Breast Cancer" (15 trials), "Lymphoma" (14 trials), "Leukemia" (10 trials) and "Trauma" (9 trials). Many other conditions were trialed in "Harborview Medical Center" in a lesser frequency.

Most popular intervention types in "Harborview Medical Center" are "Drug" (233 trials), "Other" (88 trials), "Device" (58 trials), "Biological" (54 trials) and "Behavioral" (50 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (46 trials), "Laboratory Biomarker Analysis" (20 trials), "cyclophosphamide" (16 trials), "cisplatin" (11 trials) and "radiation therapy" (11 trials). Other intervention names were less common.

The vast majority of trials in "Harborview Medical Center" are 407 trials for "All" genders, 21 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are 85 active trials in "Harborview Medical Center". 2 are not yet recruiting, 41 are recruiting, 40 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 284 completed trials in Harborview Medical Center, undefined suspended trials, and 46 terminated clinical trials to date.

Out of the total trials that were conducted in Harborview Medical Center, 26 "Phase 1" clinical trials were conducted, 137 "Phase 2" clinical trials and 104 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 105 trials that are defined as “Not Applicable".